DeepMed Research

University of Zurich

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Private

Established: 1833-04-29

Employees: 5K

Market Cap: -

Website: http://www.uzh.ch

Clinical Trials

Telephone-administered Relapse Prevention for Depression

Not Applicable

Completed

Conditions: Depressive Disorder

Interventions: Behavioral: Telephone-administered continuation therapy
Other: Usual care

First Posted Date: 2017-07-18

Last Posted Date: 2025-02-17

Lead Sponsor: University of Zurich

Target Recruit Count: 201

Registration Number: NCT03219879

Locations: 🇨🇭
Zentrum für Psychiatrie und Psychotherapie, Klinik Gais AG, Gais, Switzerland
🇨🇭
Klinik für Psychiatrie und Psychotherapie, Psychiatrisches Zentrum AR, Herisau, Switzerland
🇨🇭
Praxisstelle Psychotherapie, Universität Zürich, Zürich, Switzerland

and more 8 locations

Retrospective Data Analysis of Data From the Zurich PH Registry

Completed

Conditions: Pulmonary Hypertension
Pulmonary Artery Hypertension
Chronic Thromboembolic Pulmonary Hypertension

First Posted Date: 2017-06-26

Last Posted Date: 2019-08-13

Lead Sponsor: University of Zurich

Target Recruit Count: 313

Registration Number: NCT03198910

Locations: 🇨🇭
Respiratory Clinic, University Hospital of Zurich, Zurich, Switzerland

Frontopolar Cortex and Motivation in Healthy Older Adults

Not Applicable

Completed

Conditions: Motivation in Healthy Older Adults

Interventions: Device: transcranial direct current stimulation

First Posted Date: 2017-06-23

Last Posted Date: 2021-04-29

Lead Sponsor: University of Zurich

Target Recruit Count: 26

Registration Number: NCT03197181

Locations: 🇨🇭
University of Zurich, Zürich, Switzerland

Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension

Completed

Conditions: Pulmonary Hypertension

Interventions: Other: Hypoxia and Hyperoxia

First Posted Date: 2017-06-22

Last Posted Date: 2022-11-02

Lead Sponsor: University of Zurich

Target Recruit Count: 44

Registration Number: NCT03195959

Locations: 🇨🇭
UniversityHospital Zurich, Department of Pulmonology, Zürich, Switzerland

Effect of Short-term Oxygen During CPET in COPD

Phase 2

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Procedure: Oxygen application

First Posted Date: 2017-06-22

Last Posted Date: 2019-08-13

Lead Sponsor: University of Zurich

Target Recruit Count: 20

Registration Number: NCT03196089

Locations: 🇨🇭
University Hospital Zurich, Division of Pneumology, Zürich, Switzerland

Effect of Fluvastatin on Brown Fat Activity

Phase 4

Completed

Conditions: Adipose Tissue, Brown
Insulin Resistance
Clinical Trial

Interventions: Drug: Fluvastatin

First Posted Date: 2017-06-16

Last Posted Date: 2018-05-31

Lead Sponsor: University of Zurich

Target Recruit Count: 17

Registration Number: NCT03189511

Locations: 🇨🇭
University Hospital of Basel, Basel, Switzerland
🇨🇭
University Hospital of Zurich, PET/MR Center, Schlieren, Zurich, Switzerland

Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals

Phase 1

Completed

Conditions: Decision Making

Interventions: Drug: PF-06412562
Drug: Placebo

First Posted Date: 2017-06-09

Last Posted Date: 2020-11-05

Lead Sponsor: University of Zurich

Target Recruit Count: 120

Registration Number: NCT03181841

Locations: 🇨🇭
University Hospital Zurich, Dept. of Clinical Pharmacology and Toxicology, Zurich, Switzerland

Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Respiratory Disease at Altitude

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: ACETAZOLAMIDE oral capsule
Drug: Placebo oral capsule

First Posted Date: 2017-06-06

Last Posted Date: 2019-01-29

Lead Sponsor: University of Zurich

Target Recruit Count: 185

Registration Number: NCT03177850

Locations: 🇰🇬
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Effect of Acetazolamide on Postural Control in Patients With Respiratory Disease at Altitude

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: ACETAZOLAMIDE oral capsule
Drug: Placebo oral capsule

First Posted Date: 2017-06-06

Last Posted Date: 2021-10-12

Lead Sponsor: University of Zurich

Target Recruit Count: 127

Registration Number: NCT03177811

Locations: 🇰🇬
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Effect of Acetazolamide on Exercise Performance in Patients With Respiratory Disease at Altitude

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: ACETAZOLAMIDE oral capsule
Drug: Placebo oral capsule

First Posted Date: 2017-06-06

Last Posted Date: 2019-08-16

Lead Sponsor: University of Zurich

Target Recruit Count: 176

Registration Number: NCT03177837

Locations: 🇰🇬
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy